pMKO.1 puro Citations (12)
Originally described in: Lentivirus-delivered stable gene silencing by RNAi in primary cells.Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, Novina CD RNA 2003 Apr;9(4):493-501. PubMed Journal
Articles Citing pMKO.1 puro
| Articles |
|---|
DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases.
He YJ, McCall CM, Hu J, Zeng Y, Xiong Y.
Genes Dev. 2006 Nov 1. 20(21):2949-54.
PubMed
Associated Plasmids |
Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development.
McCall CM, Miliani de Marval PL, Chastain PD, Jackson SC, He YJ, Kotake Y, Cook JG, Xiong Y.
Mol Cell Biol. 2008 Sep . 28(18):5621-33.
PubMed
Associated Plasmids |
| Transcription factor Smad3 is required for the inhibition of adipogenesis by retinoic acid. Marchildon F, St-Louis C, Akter R, Roodman V, Wiper-Bergeron NL. J Biol Chem. 2010 Apr 23;285(17):13274-84. doi: 10.1074/jbc.M109.054536. Epub 2010 Feb 23. PubMed |
| Retinoic acid-induced Smad3 expression is required for the induction of osteoblastogenesis of mesenchymal stem cells. Dingwall M, Marchildon F, Gunanayagam A, Louis CS, Wiper-Bergeron N. Differentiation. 2011 Sep;82(2):57-65. doi: 10.1016/j.diff.2011.05.003. Epub 2011 May 25. PubMed |
| PTEN regulates colorectal epithelial apoptosis through Cdc42 signalling. Deevi R, Fatehullah A, Jagan I, Nagaraju M, Bingham V, Campbell FC. Br J Cancer. 2011 Oct 25;105(9):1313-21. doi: 10.1038/bjc.2011.384. Epub 2011 Sep 27. PubMed |
| Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models. Ma CX, Cai S, Li S, Ryan CE, Guo Z, Schaiff WT, Lin L, Hoog J, Goiffon RJ, Prat A, Aft RL, Ellis MJ, Piwnica-Worms H. J Clin Invest. 2012 Apr;122(4):1541-52. doi: 10.1172/JCI58765. Epub 2012 Mar 26. PubMed |
| Rescue of glandular dysmorphogenesis in PTEN-deficient colorectal cancer epithelium by PPARgamma-targeted therapy. Jagan I, Fatehullah A, Deevi RK, Bingham V, Campbell FC. Oncogene. 2013 Mar 7;32(10):1305-15. doi: 10.1038/onc.2012.140. Epub 2012 Apr 30. PubMed |
| DNA damage causes TP53-dependent coupling of self-renewal and senescence pathways in embryonal carcinoma cells. Jackson TR, Salmina K, Huna A, Inashkina I, Jankevics E, Riekstina U, Kalnina Z, Ivanov A, Townsend PA, Cragg MS, Erenpreisa J. Cell Cycle. 2013 Feb 1;12(3):430-41. doi: 10.4161/cc.23285. Epub 2012 Feb 1. PubMed |
| Nuclear Envelope Rupture Is Enhanced by Loss of p53 or Rb. Yang Z, Maciejowski J, de Lange T. Mol Cancer Res. 2017 Nov;15(11):1579-1586. doi: 10.1158/1541-7786.MCR-17-0084. Epub 2017 Aug 15. PubMed |
| PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer. Wozniak DJ, Kajdacsy-Balla A, Macias V, Ball-Kell S, Zenner ML, Bie W, Tyner AL. Nat Commun. 2017 Nov 15;8(1):1508. doi: 10.1038/s41467-017-01574-5. PubMed |
| HtrA4 Protease Promotes Chemotherapeutic-Dependent Cancer Cell Death. Wenta T, Rychlowski M, Jarzab M, Lipinska B. Cells. 2019 Sep 20;8(10). pii: cells8101112. doi: 10.3390/cells8101112. PubMed |
| Lysine methyltransferase 5C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis. Zeng B, Wan R, Chang K, Li J, Zhang X, Shi G, Ye D, Xu F. Int J Oncol. 2024 Apr;64(4):45. doi: 10.3892/ijo.2024.5633. Epub 2024 Mar 1. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.